Japan Medical & Health Tourism Center (JMHC) is a medical coordinator established by the JTB Group, Japan's largest travel agency.

Program Details

Information about medical programs provided by each healthcare institution, including treatment details, schedules, and costs.

Proton Beam Therapy and Multidisciplinary Approach for Lung Cancer【 Chubu International Medical Center】

Using proton beam therapy with world-class precision, we provide treatment aimed at cure while minimizing the impact on surrounding organs.
Lung cancer specialists lead a multidisciplinary team to deliver the most appropriate and comprehensive care for each patient.

We provide treatment aimed at achieving a cure.
Using a proton beam therapy system with world-class precision, we deliver highly accurate and high-dose irradiation to tumors while minimizing the impact on surrounding healthy organs.
Lung cancer specialists lead close collaboration with related clinical departments, allowing us to propose the most appropriate treatment strategy for each patient from a comprehensive perspective.
The treatment period generally ranges from approximately 2 weeks to 2 months.
The attending physician is a lung cancer specialist who has continuously contributed to clinical research and the development of treatment guidelines in the field of lung cancer, particularly in molecular targeted therapy and immunotherapy, and is highly regarded both in Japan and internationally.

Providing Medical Institution

Social Medical Corporation Koseikai, Chubu International Medical Center

〒505-8510
1-1 Kenko-no-machi, Minokamo City
https://cjimc-hp.jp/lang/en
Specialty
Non-surgical cancer treatments (head and neck cancer, liver cancer, pancreatic cancer, early-stage lung cancer, and locally advanced lung cancer), as well as non-surgical treatment for essential tremor and Parkinson’s disease.
Eligibility Criteria/Exclusions for Treatment
Medical Information Required for Eligibility Assessment Medical certificate DICOM data Patient information sheet Others: Application form for eligibility assessment (designated by our hospital)
Remarks
Eligible Diseases / Conditions Early-stage lung cancer, locally advanced lung cancer Department / Physician in Charge Lung Cancer Treatment Center Director: Dr. Toyoaki Hida